Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 14.61
-0.16 (-1.08%)
Nov 6, 2026, 3:04 PM CST
SHE:000766 Revenue
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of 179.42M CNY in the quarter ending September 30, 2026, a decrease of -25.94%. This brings the company's total for the last twelve months to 1.01B, down -18.61% year-over-year. In the year 2025, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had annual revenue of 1.17B, down -11.54%. That makes Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd the 19,511th largest company in the world by revenue and 3,571st in China.
Revenue (ttm)
1.01B
Revenue Growth
-18.61%
P/S Ratio
13.92
Revenue / Employee
685.33K
Employees
1,480
Market Cap
14.12B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | -152.60M | -11.54% |
| Dec 31, 2024 | 1.32B | -150.79M | -10.23% |
| Dec 31, 2023 | 1.47B | 2.60M | 0.18% |
| Jan 1, 2023 | 1.47B | -44.73M | -2.95% |
| Jan 1, 2022 | 1.52B | 403.68M | 36.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.